Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...
DALLAS, Feb. 19, 2021 /PRNewswire/ -- Sunoco LP (NYSE: SUN) ("SUN" or the "Partnership") on February 19, 2021, filed operational and financial results for the fiscal year ended December 31, 2020 on ...
Piraeus, Greece, July 20, 2021 (GLOBE NEWSWIRE) -- GasLog Ltd. ("GasLog") and GasLog Partners LP ("GasLog Partners" or the "Partnership" and together with GasLog, the “Group”) (NYSE: GLOP) announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback